COMBINED IMMUNOSUPPRESSIVE THERAPY WITH CYCLOSPORIN A AND AZATHIOPRINE: A SYNERGISTIC EFFECT IN THREE OF FOUR EXPERIMENTAL MODELS

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Transplantation

• Publication date

  1982-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-198212000-00001PMID 6818737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclosporin A in renal transplantation: a prospective randomized trial.

  1982cited by this paper
• Cyclosporin-A in clinical organ grafting.

  1981cited by this paper
• Cyclosporin A prolongation of segmental pancreatic and islet allograft function in rats.

  1980cited by this paper
• The use of cyclosporin A and prednisone in cadaver kidney transplantation.

  1980cited by this paper
• Vascularized pancreas versus isolated islet allografts: an immunological comparison.

  1980cited by this paper
• Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.

  1979cited by this paper
• THE COURSE OF PANCREAS ALLOGRAFTS IN RATS CONDITIONED BY SPLEEN ALLOGRAFTS1

  1978cited by this paper
• Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

  1977cited by this paper
• Side effects of steroids and their treatment.

  1975cited by this paper
• Improved technique of heart transplantation in rats.

  1969cited by this paper
• Prolonged survival of human-kidney homografts by immunosuppressive drug therapy.

  1963cited by this paper
• HOMOTRANSPLANTATION OF KIDNEY IN PATIENTS TREATED BY PREOPERATIVE LOCAL IRRADIATION AND POSTOPERATIVE ADMINISTRATION OF AN ANTIMETABOLITE (IMURAN). REPORT OF SIX CASES.

  1963cited by this paper
• THE REVERSAL OF REJECTION IN HUMAN RENAL HOMOGRAFTS WITH SUBSEQUENT DEVELOPMENT OF HOMOGRAFT TOLERANCE.

  1963cited by this paper
• RENAL HOMOTRANSPLANTATION IN MAN IN MODIFIED RECIPIENTS.

  1963cited by this paper

• THIRTY YEARS OF TACROLIMUS IN CLINICAL PRACTICE.

  2020cites this paper
• Pancreas transplantation, bioengineering, and regeneration

  2020cites this paper
• Access

  2019cites this paper
• Pancreas transplantation: 50 years of experience.

  2017cites this paper
• Trasplante de páncreas: 50 años de experiencia

  2017cites this paper
• Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis.

  2013cites this paper
• The history of kidney transplantation: Past,Present and Future

  2011cites this paper
• The History of Pancreas Transplantation: Past, Present and Future

  2008cites this paper
• Azathioprine and Steroids

  2008cites this paper
• Cyclosporine and pancreas transplantation

  2005cites this paper
• The use of cyclosporine in renal and pancreas transplantation.

  2004cites this paper
• Role of Immunosuppression Minimization Protocols in Renal Transplantation, A Review

  2004cites this paper
• Steroid immunosuppression in kidney transplantation: a passing era.

  2004cites this paper
• Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.

  2000cites this paper
• Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.

  2000cites this paper
• Use of antilymphocyte induction therapy in liver transplantation: A European perspective.

  1999cites this paper
• Mycophenolate Mofetil, Azathioprine and Cyclophosphamide Enhanced Efficacy Combined with Cyclosporine in Rat Cardiac Transplantation

  1997cites this paper
• The effect of combination therapy with EPC-K1 and low-dose cyclosporine to pulmonary allograft after rat lung transplantation.

  1997cites this paper
• Steroid withdrawal in kidney transplant recipients: is it a safe option?

  1997cites this paper
• In vivo immunosuppressive effect and the decreasing expression of MHC class II antigens by purine nucleoside phosphorylase inhibitor 8-amino-9-benzylguanine in recipient tissues of canine renal allograft rejection.

  1996cites this paper
• Osmotic Separation of Pancreatic Exocrine Cells from Crude Islet Cell Preparations

  1996cites this paper
• Osmotic separation of pancreatic exocrine cells from crude islet cell preparations.

  1996cites this paper
• Effects of steroid withdrawal on long-term renal allograft recipients with posttransplantation diabetes mellitus.

  1994cites this paper
• Double-therapy vs triple-therapy immunosuppression in cadaveric renal transplants.

  1994cites this paper
• Azathioprine does not potentiate the immunosuppressive effect of 15-deoxyspergualin in rat heart allografting.

  1994cites this paper
• Steroid withdrawal after renal transplantation

  1994cites this paper
• The synergistic interactions in vitro and in vivo of brequinar sodium with cyclosporine or rapamycin alone and in triple combination.

  1993cites this paper
• MONOCLONAL ANTIBODIES IN PROPHYLACTIC IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION A RANDOMIZED CONTROLLED TRIAL COMPARING OKT3 AND ANTI‐IL-2 RECEPTOR MONOCLONAL ANTIBODY LO‐TACT-1

  1993cites this paper
• Urinary mutagenic activity after different immunosuppressive protocols in renal transplant patients.

  1993cites this paper
• Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota.

  1993cites this paper
• Immunosuppressive Drug Regimens following Renal Transplantation: Cost and Effectiveness Analyses

  1992cites this paper
• Immunosuppressive therapy.

  1992cites this paper
• Cyclosporin A, FK506, rapamycin: the use of a quantitative analytic tool to discriminate immunosuppressive drug interactions.

  1992cites this paper
• Synergism, how assessed and how achieved

  1991cites this paper
• Triple agent immunosuppression in serpiginous choroiditis.

  1991cites this paper
• A RANDOMIZED PROSPECTIVE TRIAL COMPARING CYCLOSPORINE MONOTHERAPY WITH TRIPLE‐DRUG THERAPY IN RENAL TRANSPLANTATION

  1991cites this paper
• Renal allograft immunosuppression

  1991cites this paper
• Renal allograft immunosuppression: II. A randomized trial of withdrawal of one drug in triple drug immunosuppression

  1990cites this paper
• A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients.

  1990cites this paper
• Effects of initial cyclosporine dose and timing on long‐term creatinine levels in cadaver renal transplantation

  1990cites this paper
• Cyclosporine in the treatment of acute vascular rejection of renal allografts.

  1990cites this paper
• Triple therapy immunosuppression in cadaveric renal transplantation

  1990cites this paper
• Renal allograft immunosuppression

  1990cites this paper
• Low‐dose ciclosporin mizoribine and prednisolone in renal transplantation: A new triple‐drug therapy

  1990cites this paper
• Experience with cyclosporine A and azathioprine double therapy in low‐risk recipients of first cadaveric renal allografts

  1990cites this paper
• Immunosuppression for cadaveric renal allograft recipients: A risk‐factor matched comparison of the Minnesota Randomized Trial with an antilymphoblast globulin, azathioprine, cyclosporine, and prednisone protocol

  1989cites this paper
• Cadaveric renal transplantation under the American organ allocation system.

  1989cites this paper
• Steroid withdrawal in cyclosporine-treated living related donor renal transplant recipients.

  1989cites this paper
• Immunosuppression for pancreas transplant recipients

  1989cites this paper
• Pharmacology of cyclosporine (sandimmune). IV. Pharmacological properties in vivo.

  1989cites this paper
• Effect of elimination of OX-19+ and OX-8+ T-cell subsets upon pancreatic allograft survival.

  1989cites this paper
• A new triple-drug induction therapy with low dose cyclosporine, mizoribine and prednisolone in renal transplantation.

  1989cites this paper
• Renal transplantation in black recipients at the University of Pittsburgh.

  1989cites this paper
• Coming of age for pancreas transplantation.

  1989cites this paper
• The influence of cyclosporin A on T cell activation, cytokine gene expression and cell-mediated immunity

  1989cites this paper
• Long-term survival of kidney allografts in dogs after withdrawal of immunosuppression with ciclosporin and azathioprine.

  1989cites this paper
• A RANDOMIZED TRIAL COMPARING CYCLOSPORINE WITH ANTILYMPHOBLAST‐GLOBULIN—AZATHIOPRINE FOR RENAL ALLOGRAFT RECIPIENTS: Results At 2–1/2–6 Years

  1988cites this paper
• A RANDOMIZED TRIAL COMPARING TRIPLE‐DRUG AND DOUBLE‐DRUG THERAPY IN RENAL TRANSPLANTATION

  1988cites this paper
• Results of steroid withdrawal in renal allograft recipients on low‐dose cyclosporine A, azathioprine and prednisolone

  1988influential citation
• Cadaveric renal transplantation at the University of Pittsburgh: a two and one-half-year experience with the point system.

  1988cites this paper
• COMPLETE REPLACEMENT OF METHYLPREDNISOLONE BY AZATHIOPRINE IN CYCLOSPORINE‐TREATED PRIMARY CADAVERIC RENAL TRANSPLANT RECIPIENTS1 Pressented at the 6th Annual Meeting of the American Society of Transplant Physicians, May 1987, Chicago, IL

  1988cites this paper
• 31P nuclear magnetic resonance spectroscopy of heart, heart-lung, and kidney allograft rejection in the rat.

  1988cites this paper
• A new microvascular model for noninvasive nuclear magnetic resonance spectroscopy of the transplanted kidney.

  1988cites this paper
• 31P NUCLEAR MAGNETIC RESONANACE STUDY OF RENAL ALLOGRAFT REJECTION IN THE RAT

  1988cites this paper
• Atrial natriuretic factor (ANF) levels are elevated in rats bearing rejecting heart-lung allografts.

  1987cites this paper
• Pancreas transplantation at the University of Minnesota: donor and recipient selection, operative and postoperative management, and outcome.

  1987cites this paper
• 31P nuclear magnetic resonance study of acute renal dysfunction in rat kidney transplants

  1987cites this paper
• The effect of cyclosporine on native renal function in non-uremic diabetic recipients of pancreas transplants.

  1987cites this paper
• Low-dose azathioprine is synergistic with low-dose cyclosporine in rabbit skin allograft survival.

  1987cites this paper
• THE SYNERGISTIC EFFECT OF CYCLOSPORINE AND MIZORIBINE ON HETEROTOPIC HEART AND PARTIAL‐LUNG TRANSPLANTATION IN RATS

  1987cites this paper
• Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.

  1987cites this paper
• Daily and alternate-day cyclosporine immunosuppressive regimens and synergism with azathioprine.

  1987cites this paper
• The University of Wisconsin experience in pancreas transplantation.

  1987cites this paper
• Prevention of graft-versus-host disease by immunosuppressive agents after transplantation of DLA-nonidentical canine marrow.

  1986cites this paper
• Control of rejection of transplanted organs.

  1986cites this paper
• Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine.

  1986cites this paper
• Effect of cyclosporine on established islet autografts.

  1986cites this paper
• Experimental transplantation.

  1986cites this paper
• COMPARISON OF THE IMMUNOGENICITY OF PURIFIED AND UNPURIFIED MURINE ISLET ALLOGRAFTS

  1986cites this paper
• Cyclosporin A Blood Levels in Rats After Different Modes of Administration

  1985cites this paper
• [Pancreas transplantation: status of the problem in experimental and clinical medicine].

  1985cites this paper
• One institution's experience with pancreas transplantation.

  1985cites this paper
• Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.

  1985cites this paper
• Nephrotoxicity of cyclosporine.

  1985cites this paper
• A Single Institution, Randomized, Prospective Trial of Cyclosporine Versus Azathioprine‐Antilymphocyte Globulin for Immunosuppression in Renal Allograft Recipients

  1985cites this paper
• [Indefinite survival of pancreatic allografts under cyclosporin A treatment in rats].

  1984cites this paper
• COMBINED IMMUNOSUPPRESSION WITH CYCLOSPORINE AND METHOTREXATE IN DOGS GIVEN BONE MARROW GRAFTS FROM DLA‐HAPLOIDENTICAL LITTERMATES

  1984cites this paper
• Cyclosporine and pancreas transplantation

  1984cites this paper
• One Hundred Pancreas Transplants at a Single Institution

  1984cites this paper
• THE EFFECT OF DONOR‐SPECIFIC TRANSFUSIONS ON RAT HEART ALLOGRAFT SURVIVAL

  1984cites this paper
• Transplantation of Pancreas and Islets

  1984cites this paper
• Renal transplantation update.

  1984cites this paper
• Diminished synthesis of immunoglobulins by lymphocytes of patients treated with thymosin (TFX) and cyclophosphamide.

  1983cites this paper
• Cyclosporin A for Immunosuppression: Observations in Rat Heart, Pancreas, and Islet Allograft Models and in Human Renal and Pancreas Transplantation

  1982cites this paper